Mycobacteriaceae

Mycobacteriaceae

Mycobacterium tuberculosis under a microscope

The Mycobacteriaceae is a family of actinobacteria, which includes the genus Mycobacterium. This family is notable for containing species that are pathogenic to humans and animals, most famously Mycobacterium tuberculosis, the causative agent of tuberculosis.

Characteristics

Members of the Mycobacteriaceae family are characterized by their acid-fast properties, which are due to the high lipid content in their cell walls. This unique cell wall structure makes them resistant to many common antibiotics and disinfectants. The cell wall contains mycolic acids, which are long-chain fatty acids that contribute to the bacteria's hydrophobicity and resistance to desiccation.

Genus Mycobacterium

The genus Mycobacterium is the most well-known within the Mycobacteriaceae family. It includes several important species:

• Mycobacterium tuberculosis: The primary cause of tuberculosis in humans. It is a slow-growing bacterium that primarily affects the lungs but can also affect other parts of the body.
• Mycobacterium leprae: The causative agent of leprosy, a chronic infectious disease that affects the skin, peripheral nerves, and mucosa of the upper respiratory tract.
• Mycobacterium bovis: Primarily affects cattle but can also infect humans, causing a form of tuberculosis.

Pathogenicity

Mycobacteria are known for their ability to cause chronic diseases. Tuberculosis and leprosy are the most significant diseases caused by mycobacteria. These bacteria are capable of surviving within macrophages, which are cells of the immune system that typically engulf and destroy pathogens. This ability allows them to persist in the host for long periods, leading to chronic infections.

Diagnosis and Treatment

Diagnosis of mycobacterial infections often involves microscopy, culture, and molecular techniques such as PCR. The Ziehl-Neelsen stain is a common method used to identify acid-fast bacilli in clinical samples.

Treatment of mycobacterial infections can be challenging due to the bacteria's resistance to many antibiotics. Tuberculosis treatment typically involves a combination of antibiotics over an extended period, often six months or more. Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) are significant public health challenges.

Related Pages

• Tuberculosis
• Leprosy
• Antibiotic resistance
• Actinomycetota